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This article gives a short overview of the development and
characteristics of the OMERACT rheumatoid arthritis MRI
scoring system (RAMRIS), followed by an introduction to
the use of the EULAR–OMERACT rheumatoid arthritis MRI
reference image atlas. With this atlas, MRIs of wrist and
metacarpophalangeal joints of patients with rheumatoid
arthritis can be scored for synovitis, bone oedema, and
bone erosion, guided by standard reference images.
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S
tructural joint damage, a major outcome in
rheumatoid arthritis (RA), has traditionally
been measured by scoring methods applied
to radiological images.1 However, only the late
signs of preceding disease activity can be
visualised by radiography. Magnetic resonance
imaging (MRI) can detect RA erosive change
with greater sensitivity than conventional radio-
graphy, particularly in early disease.2–4 In addi-
tion, MRI allows direct visualisation and
assessment of synovitis, the primary lesion in
RA, and of bone oedema, a finding unique to
MRI and a probable forerunner of bone ero-
sions.5 6 Given these advantages, MRI has a
major potential as an outcome measure in RA
clinical trials but standardised, validated, and
feasible assessment systems are needed.
THE OMERACT AND EULAR MRI IN RA
WORKING GROUPS
Since 1998, an international Outcome Measures
in Rheumatology Clinical Trials (OMERACT)
MRI in RA working group has aimed to develop
MRI scoring systems to assess RA inflammation
(activity) and damage, which would satisfy the
elements of the OMERACT filter (truth, discri-
mination, and feasibility).7 The group’s work has
mainly focused on semiquantitative assessments
of RA wrist and metacarpophalangeal (MCP)
joints. The wrist and MCP joints were prioritised
because of their frequent involvement in RA
(including early RA), the fact that these joints
are included in traditional clinical and radiolo-
gical scoring systems in RA, and the large
amount of MRI data on these joints.8–12 MRI
definitions of important RA joint pathologies and
a core set of basic MRI sequences to be used for
imaging of the RA joint have been suggested by
the group, in order to increase comparability
between future studies.13 Furthermore, based on
a series of studies performed by an European
League Against Rheumatism (EULAR) MRI in
RA working group,14 15 and particularly the
OMERACT group,16–18 an RA MRI scoring system
(OMERACT 2002 RAMRIS) for evaluation of
inflammatory and destructive changes in RA
hands and wrists was presented at OMERACT 6
in Brisbane, Australia, in April 2002. OMERACT
6 participants endorsed the OMERACT 2002
RAMRIS as a standard comparator for new/
alternative MRI methods for RA assessment and
encouraged its further testing in longitudinal
studies.19 Recent data have documented good
intraobserver and interobserver agreements
among trained, calibrated readers20 21 and indi-
cate an improved sensitivity to change for erosive
joint damage by using this MRI score as
compared with radiography.6 22 The evidence for
the validity of MRI for assessment of joint
inflammation and destruction in RA is reviewed
elsewhere.23 24
Our group felt that the performance and
generalisability of RAMRIS scoring could be
improved by availability of a set of standard
reference images (atlas), as synovitis scores in
particular may be difficult for new readers to
conceptualise. Therefore, it was decided to focus
the group’s efforts on developing the reference
image atlas presented in this supplement for use
as a guide to scoring of RA joint pathology, based
on the OMERACT 2002 RAMRIS method.
SCORING USING THE EULAR–OMERACT
RA MRI REFERENCE IMAGE ATLAS
The OMERACT MRI in RA definitions of
important joint pathologies and scoring system13
are summarised in table 1. Examples of score
sheets, which can be used when scoring MCP
and wrist joints, are provided in fig 1.
The methodology of the development of the
atlas is described in detail in the following
paper by Bird et al.25 Next, the atlas itself is
presented26 27:
N a complete series of all grades of synovitis in
the MCP joints and in each of the wrist
joint areas (distal radioulnar joint, radiocarpal
joint and intercarpal-carpometacarpal joints);
and
N a selection of grades of bone erosions and
bone oedema in the two MCP joint bones
(metacarpal head and phalangeal base) and
five selected wrist joint bones (distal radius,
scaphoid, lunate, capitate, metacarpal base).
Abbreviations: EULAR, European League Against
Rheumatism; MCP, metacarpophalangeal; MRI, magnetic
resonance imaging; OMERACT, Outcome Measures in
Rheumatology Clinical Trials; RA, rheumatoid arthritis
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Figure 1 Examples of score sheets that can be used for scoring (A) metacarpophalangeal and (B) wrist joints using the OMERACT 2002 rheumatoid
arthritis magnetic resonance imaging scoring system (RAMRIS). The layout of the score sheet can be modified—for example, according to the features
and joints that are to be examined in a specific patient material.
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The final paper by McQueen et al describes the common and
important pitfalls involved in scoring MR images of RA wrist
and MCP joints.28
To use the atlas adequately, the reader is obviously
required to have a detailed understanding of the relevant
joint anatomy, the RA disease process, the MRI appearance of
RA joints using common sequences, and the main pitfalls
when assessing them. Furthermore, the ‘‘requirements’’ of
the OMERACT RAMRIS13 (see table 1) and the content of the
atlas25–28 should be known. Calibration with a trained reader
is recommended. Given these requirements, scoring of hard
copy or digital MR image sets of wrist and MCP joints can be
performed guided by the standard reference images of MCP
joints26 and wrist joints27 provided in this supplement.
We suggest that when using this atlas, the reader compares
the relevant images with the images in this atlas. Synovitis is
scored from 0 to 3 in each area to be evaluated (see table 1).
The MRI set to be assessed should be compared with the axial
precontrast and postcontrast T1 weighted reference images
and the joint assigned the score of the best possible match.
This is similar to the Larsen method for scoring radiographs.9
In the atlas, examples of both the ‘‘low’’ and the ‘‘high’’ end
of the spectrum of the individual grade are provided to
illustrate the range of the grade (see Bird et al25 for details).
Bone erosion is graded by percentage volume (0–10, by
10% volume increments) of the assessed bone as described in
the OMERACT RAMRIS (see table 1). All coronal slices
covering the bone must be assessed to estimate the
percentage of the total volume occupied by the erosion.
Even though only a subset of bones are illustrated in the
atlas, we recommend that all bones in the wrist and MCP
joints should be scored. The reference images in the atlas can
be used for guidance and calibration.
Bone oedema is graded by percentage volume (0–3, by 33%
volume increments) of the assessed bone as described in the
OMERACT RAMRIS (table 1). As for erosion, all slices
covering the bone need to be taken into account. It should be
emphasised that oedema, in case erosion and oedema are
concurrently present, is scored as a proportion of the
estimated original bone volume, not of the remaining bone.
Table 1 OMERACT MRI in RA group recommendations of a core set of basic MRI sequences, MRI
definitions of important RA joint pathologies, and an RA MRI scoring system (OMERACT 2002 RAMRIS).13
A. Core set of basic MRI sequences
It is suggested that future MRI studies that intend to assess inflammatory as well as destructive changes in RA joints should at least
include the following:
N Imaging in two planes* with T1 weighted images before and after intravenous gadolinium contrast
N A T2 weighted fat saturated sequence or, if the latter is not available, a STIR (short tau inversion recovery) sequence
*Can be acquired by obtaining a two dimensional sequence in two planes, or a three dimensional sequence with isometrical voxels
in one plane allowing reconstruction in other planes.
Intravenous gadolinium injection is probably not essential if only destructive changes (bone erosions) are considered important.
B. Definitions of important RA joint pathologies
N Synovitis: an area in the synovial compartment that shows above normal post-gadolinium enhancement* of a thickness
greater than the width of the normal synovium
N MRI bone erosion: a sharply marginated bone lesion, with correct juxta-articular localisation and typical signal
characteristics, which is visible in two planes with a cortical break seen in at least one plane`
N MRI bone oedema: A lesion within the trabecular bone, with ill defined margins and signal characteristics consistent
with increased water content1
* Enhancement is judged by comparison of T1 weighted images obtained before and after intravenous gadolinium contrast.
An T1 weighted images this is loss of normal low signal intensity of cortical bone and loss of normal high signal intensity of
trabecular bone. Quick post-gadolinium enhancement suggests presence of active, hypervascularised pannus tissue in the erosion.
` Other focal bone lesions, including metastases must obviously be considered but are generally distinguishable with associated
imaging and clinical findings.
 May occur alone or surrounding an erosion or other bone abnormalities.
1 High signal intensity on weighted fat saturated and STIR images, and low signal intensity on T1 weighted images.
C. Scoring system (OMERACT 2002 RAMRIS)
N Synovitis: is assessed in three wrist regions (the distal radioulnar joint; the radiocarpal joint; the intercarpal and
carpometacarpal joints) and in each MCP joint. The first carpometacarpal joint and the first MCP joint are not scored. The
scale is 0–3. Score 0 is normal, and 1–3 (mild, moderate, severe) are by thirds of the presumed maximum volume of
enhancing tissue in the synovial compartment
N Bone erosions: each bone (wrists: carpal bones, distal radius, distal ulna, metacarpal bases; MCP joints: metacarpal
heads, phalangeal bases) is scored separately. The scale is 0–10, based on the proportion of eroded bone compared to
the ‘‘assessed bone volume’’, judged on all available images—0: no erosion; 1: 1–10% of bone eroded; 2; 11–20%, etc.
For long bones, the ‘‘assessed bone volume’’ is from the articular surface (or its best estimated position if absent) to a
depth of 1 cm, and in carpal bones it is the whole bone
N Bone oedema: each bone is scored separately (as for erosions). The scale is 0–3 based on the proportion of bone with
oedema, as follows—0: no oedema; 1: 1–33% of bone oedematous; 2: 34–66% of bone oedematous; 3: 67–100%
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All bones of the wrist and second to fifth MCP joints should
be scored, not just the subset illustrated. The atlas reference
images can be used for guidance and calibration.
Sum scores of synovitis, erosion, and oedema can be
calculated by summation of individual joint scores, as a total
sum or separately in the evaluated wrist and second to fifth
MCP joints, respectively. For synovitis, the possible range of
sum scores of unilateral second to fifth MCP joints, wrist
joint, and both are 0–12, 0–9, and 0–21, respectively. The
corresponding values for bone erosion are 0–80, 0–150,
and 0–230 and for bone oedema 0–24, 0–45, and 0–69,
respectively.
In conclusion, we hope we have provided a user friendly
tool for teaching new readers and improving calibration for
all who use MRI outcomes in RA clinical trials.
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